Blog Archives

Tradeshow Event: Partnership in Clinical Trials

The Mirage Hotel
Las Vegas, NV
March 31 – April 2 2014

Conference home page

We will be exhibiting at booth #1305 . We will be demonstrating out Kinesia HomeView and ProView systems.

Read more ›



PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by adding real-time video conferencing.

Read more ›



PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS) and pharmaceutical therapies. 

Read more ›



PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine

VIEW PRESS RELEASE [PDF]

13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress in Dublin, Ireland.  The Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/  ] system includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor,

Read more ›



PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of motor symptoms associated with movement disorders.  

Read more ›



Top